Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purposes of this study are
By reaching the above list purposes, sarcopenia can be viewed as one of serious post stroke complications that is closely related to worth functional outcome, thereby emphasizing the importance of evaluation of sarcopenia as well as its prevention.
Sarcopenia occurs frequently among old population. The changes can rather occur earlier after trauma or generalized illness. However, the nature of these sarcopenia is different from that of geriatric population. Post stroke sarcopenia is underestimated however reduction in the motor uni number begins within 4 hours post stroke and after 3 weeks, sarcopenia can be seen in both hemiplegia and normal side. This muscular weakness can hinder functional recovery process.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Normal subjects without stroke |
| ||
| Post stroke patients with sarcopenia(by sarcopenia index) | Existence of sarcopenia will be determined by DEXA scan where sarcopenia index of male less than 7.40 kg/m2, that of female less than 5. 14 kg/m2 are considered as sarcopenia. | ||
| Post stroke patients without sarcopenia(by sarcopenia index) | patients who do not satisfy the value of DEXA scan where sarcopenia index of male less than 7.40 kg/m2, that of female less than 5. 14 kg/m2 are considered as sarcopenia. | ||
| Post stroke patients with sarcopenia(by lean body mass) | Existence of sarcopenia will be determined by DEXA scan where appendicular lean mass less than <19.75 kg in men, and <15.02 kg in women are considered sarcopenia. | ||
| Post stroke patients without sarcopenia(by lean body mass) | patienst who do not satisfy the value of DEXA scan where appendicular lean mass less than <19.75 kg in men, and <15.02 kg in women are considered sarcopenia. |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Change in K-MBI score from initial evaluation to the final evaluation | 8 weeks, 12 weeks, 16 weeks from the first onset of the stroke |
| Measure | Description | Time Frame |
|---|---|---|
| Change in Berg balance scale from initial evaluation to the final evaluation | 8 weeks, 12 weeks, 16 weeks from the first onset of the stroke | |
| Change in Fatigue scale from initial evaluation to the final evaluation | 8 weeks, 12 weeks, 16 weeks from the first onset of the stroke |
Not provided
Inclusion Criteria for stroke patients
Exclusion Criteria: for stroke patients
Inclusion Criteria for normal subjects
Exclusion Criteria for normal subjects
Not provided
Not provided
Not provided
Recruited subjects will be allocated into 3 different groups.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Geun-Young Park | Bucheon St. Mary's Hospital | Study Director |
| Yongmin Choi | Bucheon St. Mary's Hospital | Principal Investigator |
| Sun Im | Bucheon St. Mary's Hospital | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Bucheon St. Mary's Hospital | Bucheon-si | Gyeonggi-do | 14647 | South Korea |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D055948 | Sarcopenia |
| ID | Term |
|---|---|
| D009133 | Muscular Atrophy |
| D020879 | Neuromuscular Manifestations |
| D009461 | Neurologic Manifestations |
| D009422 | Nervous System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| Change in Motricity index from initial evaluation to the final evaluation | 8 weeks, 12 weeks, 16 weeks from the first onset of the stroke |
| Change in Functional Oral Intake Scale (FOIS) from initial evaluation to the final evaluation | 8 weeks, 12 weeks, 16 weeks from the first onset of the stroke |
| Change in MMSE from initial evaluation to the final evaluation | 8 weeks, 12 weeks, 16 weeks from the first onset of the stroke |
| D001284 | Atrophy |
| D020763 | Pathological Conditions, Anatomical |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D012816 | Signs and Symptoms |